Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
Lancet Diabetes and Endocrinology
Journal
Overview
Identity
Overview
Publication Venue For
Metabolic risk factors and effect of alirocumab on cardiovascular events after acute coronary syndrome: a post-hoc analysis of the ODYSSEY OUTCOMES randomised controlled trial
. 10:330-340.
2022
Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study
. 7:899-911.
2019
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial
. 7:618-628.
2019
Effect of testosterone replacement on measures of mobility in older men with mobility limitation and low testosterone concentrations: secondary analyses of the Testosterone Trials
. 6:879-890.
2018
Denosumab versus risedronate in glucocorticoid-induced osteoporosis: a multicentre, randomised, double-blind, active-controlled, double-dummy, non-inferiority study
. 6:445-454.
2018
Natriuretic peptides and integrated risk assessment for cardiovascular disease: an individual-participant-data meta-analysis
. 4:840-849.
2016
Does midlife obesity really lower dementia risk?
. 3:501.
2015
Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: A collaborative meta-analysis of individual participant data
. 3:514-525.
2015
Diabetic kidneys do deserve a lifestyle change
. 2:776.
2014
Effect of a long-term behavioural weight loss intervention on nephropathy in overweight or obese adults with type 2 diabetes: A secondary analysis of the Look AHEAD randomised clinical trial
. 2:801-809.
2014
Once-weekly albiglutide versus once-daily liraglutide in patients with type 2 diabetes inadequately controlled on oral drugs (HARMONY 7): A randomised, open-label, multicentre, non-inferiority phase 3 study
. 2:289-297.
2014
The Look AHEAD study: A missed opportunity - Authors' Reply
. 2:776.
2014
Identity
International Standard Serial Number (issn)
2213-8587
Electronic International Standard Serial Number (eissn)
2213-8595